Facebook
Twitter
LinkedIn
ForwardPatient Safety Course (2021)
The Patient Safety Course is designed to provide urologists and the urology care team with the knowledge required to apply appropriate patient safety procedures in a urologic practice. Urology specific examples will help learners understand patient safety concepts, how safety issues arise, and how they can be mitigated.
The AUA Office of Education has produced this instructive Safety Module which appropriately addresses the need for and establishment of a safety culture to prevent systemic error. Completion of this module, along with the pre and post testing, satisfies the American Board of Urology’s safety module requirement at year 4 of the Life Long Learning (LLL) program.
Target Audience
- Urologists
- Residents
- Medical Students
- Advanced Practice Providers
Learning Objectives
After completing this activity, the participants will be able to
- Define patient safety and medical error.
- Create a vision of patient safety in their practice.
- Apply just culture to their practice.
- Define the role of communication in improving patient safety.
- Describe public reporting of safety and quality data.
Course Director
Timothy Averch, MD: Canadian Journal of Urology: Health Publishing; Journal of Endourology: Health Publishing
Faculty
Sam Bhayani, MD: Conmed: Consultant or Advisor, Investment Interest
Zachary Gordon, MD: AUA: Leadership Position, Consultant or Advisor, Other
Kristin Chrouser: Nothing to disclose
Chuck Scales, MD: NIH/National Institute on Aging: Scientific Study or Trail; Society of Urology Chairpersons and Program Directors: Scientific Study or Trial; Filament Biosolutions: Scientific Study or Trial; NIH/National Institute of Diabetes and Digestive and Kidney Diseases: Scientific Study or Trial; Gilead: Consultant or Advisor; Astra-Zeneca: Scientific Study or Trial
Planner Disclosures
QIPS Committee Disclosures Education Council Disclosures
AUA Office of Education Staff has nothing to disclose.
METHOD OF PARTICIPATION:
Learners will participate in this online educational activity by taking the pretest, viewing the online modules and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.
Estimated time to complete this activity:1.25 hours
Release Date: January, 2021
Original Release Date: January, 2018
Expiration Date: January, 2024
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.